Given the increase in PD-1–expressing T cells observed in patients who recovered from COVID-19 and the role of the PD-1/PD-L1 axis in exhaustion onset, we sought to further confirm dysregulation of the PD-1/PD-L1 pathway in COVID-19. Here, CD274 is linked to COVID-19.